Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

Report on Activities for the Quarter ended 31 March 2024

26 April 2024 by Audrey Thomson

Report on Activities for the Quarter Ended 31 March 2024

Categories 2024, ASX Announcements

Positive Outcomes in BIT225 Phase 2 Clinical Trial in HIV-1 (BIT225-010)

Quarterly Report 31 March 2024

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 6 September 2024 Legal Notices and Privacy